SC 13G
ATOSSA THERAPEUTICS, INC.
- Company
- ATOSSA THERAPEUTICS, INC.
- Filed
- January 14, 2021
- Accession Number
- 0000902664-21-000205
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →